Is Arcadia Biosciences, Inc. technically bullish or bearish?
2025-09-20 19:35:53As of 10 September 2025, the technical trend for Arcadia Biosciences, Inc. has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and mildly bearish signals from the Bollinger Bands and KST on the weekly. The Dow Theory indicates no trend on the weekly but is mildly bearish on the monthly. In terms of performance, the stock has underperformed the S&P 500 over the last month with a return of -18.01% compared to the S&P 500's 2.33%, and it has significantly lagged over the year-to-date with a return of -38.09% versus the S&P 500's 12.22%....
Read MoreIs Arcadia Biosciences, Inc. overvalued or undervalued?
2025-09-20 18:10:58As of 30 March 2022, the valuation grade for Arcadia Biosciences, Inc. moved from fair to risky, indicating a shift towards a more negative outlook. The company appears to be overvalued given its P/E ratio of 7, which is significantly lower than the industry average, and a PEG ratio of 0.07, suggesting limited growth prospects. Additionally, the EV to EBITDA ratio of -0.76 further highlights the company's financial struggles. In comparison to peers, Arcadia's valuation metrics are concerning; for instance, Oil-Dri Corp. of America has a P/E ratio of 25.16, showcasing a stark contrast in valuation. Other risky peers, such as LSB Industries, Inc. and Bioceres Crop Solutions Corp., also reflect negative EV to EBITDA ratios, indicating that Arcadia is not alone in its challenges but still stands out with its particularly low ratios. Over the past year, while Arcadia's stock returned 26.38%, it underperformed a...
Read More





